Review
Previous medications, doses, duration, side effects, and response.
1201 East Schuster Suite 1A, El Paso, TX 79902
Phone: 915-505-9713
Hours: M-F 8am-5pm, Sat-Sun: Closed
Treatment-Resistant Depression (TRD) occurs when depression persists after trying at least two adequate antidepressant treatments. It doesn't mean you are out of options—it means your care plan needs a fresh, individualized review.
Taking an antidepressant is not a small decision. When you have followed the plan, waited for the medication to work, attended appointments, and still feel depressed, it can be frustrating to hear that the answer is simply to "give it more time." Sometimes more time is appropriate. Other times, persistent symptoms are a sign that the treatment plan needs a closer look.
Treatment-resistant depression, often shortened to TRD, is a clinical term for depression that has not improved enough after appropriate treatment attempts. It does not mean that you are out of options or that your depression can never improve. It means your care may need to become more individualized, with a careful review of what has already been tried and what should come next.
For adults in El Paso, that next step may include a medication adjustment, psychotherapy, transcranial magnetic stimulation (TMS), SPRAVATO® (esketamine), or another approach based on diagnosis, treatment history, safety, and personal goals.
The National Institute of Mental Health notes that treatment-resistant depression occurs when a person does not get better after trying at least two antidepressants. In practice, clinicians also look at whether those medication trials were adequate. That includes questions about dose, how long the medication was taken, side effects, adherence, and whether symptoms changed at all.
This distinction matters because "this medication did not work" can describe several different situations. One medication may have caused side effects before there was enough time to judge its benefit. Another may have helped sleep and energy without lifting low mood. A third may have worked for a period and then stopped providing the same relief. Those details help a psychiatric provider decide whether the depression is truly resistant to standard treatment or whether the current plan needs refinement.
If you are still trying to understand the severity of your symptoms, MindBliss Psychiatry also offers a PHQ-9 depression screening. A screening tool can help organize symptoms, but it is not a diagnosis and does not determine which treatment is right for you.
Persistent depression deserves a fresh clinical review, not just an automatic switch to another medication. Depression symptoms can be affected by sleep problems, substance use, medical conditions, major life stress, medication interactions, and other psychiatric conditions. Bipolar disorder, for example, requires a different treatment approach than unipolar major depression.
A provider may also want to revisit past medication trials in detail. Which medications were used? At what doses? For how long? What improved, what did not, and what side effects made treatment difficult? A structured psychiatric medication-management visit can turn a long list of previous prescriptions into a clearer treatment history.
This review is not about proving that you "failed" treatment. The purpose is to identify patterns. A partial response may point toward adjustment or augmentation. Intolerable side effects may make a nonmedication option more appealing. A change in diagnosis may shift the entire plan.
There is no single symptom that proves someone has treatment-resistant depression. Still, it is reasonable to ask for a treatment review when:
A provider can help determine whether the next step should be another medication strategy, psychotherapy, an advanced treatment, or a combination. The goal is not to move to the most intensive option as quickly as possible. It is to choose the next option for a clear clinical reason.
Persistent symptoms do not automatically mean treatment resistance, but they are worth discussing with a psychiatric provider.
Sometimes the next step remains medication-based. A psychiatric provider may consider optimizing the current antidepressant, switching to another medication, or adding a different type of medication to improve response. NIMH notes that combining an antidepressant with another medication is one option used in treatment-resistant depression. The right strategy depends on your diagnosis, prior response, side effects, medical history, and other medications.
Medication is only one part of depression treatment. Psychotherapy can help address patterns of thinking and behavior, coping skills, relationships, loss, stress, and other factors that can keep depression disruptive. Even when therapy did not seem helpful in the past, the type of therapy, treatment goals, therapeutic relationship, and timing can make a difference. Many patients benefit from coordinated medication and therapy rather than treating them as competing choices.
TMS is a noninvasive brain-stimulation treatment that uses magnetic pulses to stimulate targeted brain circuits. The NIMH overview of brain-stimulation therapies describes repetitive TMS as an FDA-cleared option for treatment-resistant depression. It does not require anesthesia, and treatment is generally delivered as a series of outpatient sessions.
MindBliss offers TMS therapy in El Paso for adults with depression who have given medication a fair try but continue to have symptoms that interfere with daily life. A psychiatric evaluation is needed to determine whether TMS is appropriate.
SPRAVATO® is an esketamine nasal spray used under medical supervision. Current FDA prescribing information lists SPRAVATO® for treatment-resistant depression in adults either as monotherapy or in conjunction with an oral antidepressant. Because the medication can cause sedation, dissociation, respiratory depression, and increases in blood pressure, it is administered in a certified clinical setting with monitoring.
TMS and SPRAVATO® are very different treatments, and neither is automatically the better choice. If you are already comparing them, MindBliss has a detailed guide to
TMS vs. SPRAVATO® in El Paso that explains the practical differences between the two.
When depression has persisted through more than one treatment attempt, the most useful appointment is often one that looks backward before looking forward. Bring the names of previous medications if you have them, approximate dates or treatment lengths, side effects, previous therapy experience, hospitalizations, relevant medical conditions, and any information about what helped even a little.
At MindBliss Psychiatry, adult depression care can be coordinated across medication management, psychotherapy, TMS, and SPRAVATO® from its El Paso clinic. That gives the treatment conversation room to focus on fit rather than forcing every patient into the same pathway.
You may leave an evaluation with a recommendation to adjust a medication rather than begin an advanced treatment. You may learn that TMS or SPRAVATO® is worth exploring. You may need additional diagnostic clarification first. Any of those outcomes can be useful if they turn an unclear treatment history into a more deliberate plan.
When depression has persisted through several treatment attempts, looking backward can make the next decision clearer.
Previous medications, doses, duration, side effects, and response.
Current symptoms, diagnosis, medical factors, and safety considerations.
Medication, therapy, TMS, SPRAVATO®, or combinations that may fit.
Create a treatment direction based on your history and personal goals.
If you have tried antidepressants and still feel stuck, the next step is not to assume that nothing will help. It is to get specific about what has been tried, what symptoms remain, and which options make sense from here.
MindBliss Psychiatry is accepting new adult patients in El Paso and serves people across El Paso County and nearby Doña Ana County. A psychiatric evaluation can help determine whether your next step involves medication management, psychotherapy, TMS, SPRAVATO®, or another individualized treatment approach.
If you are in immediate danger, call 911. If you are experiencing suicidal thoughts or an emotional crisis, call or text
988 to reach the 988 Suicide & Crisis Lifeline.
This article provides general information and is not a diagnosis or individualized medical recommendation. Treatment decisions should be made with a qualified health care professional.
A common definition is inadequate improvement after at least two antidepressant trials. Your provider will also consider whether each trial was adequate in dose and duration and whether the medication was tolerated and taken as directed.
No. TRD describes the response to treatment so far, not a permanent prognosis. Some people benefit from a different medication strategy, augmentation, psychotherapy, TMS, SPRAVATO®, or a combination selected after a careful reassessment.
No. TMS may be considered for adults whose depression has not improved enough with medication or who have had difficulty tolerating medication. Candidacy depends on an individual psychiatric and safety evaluation.
Do not stop or change a psychiatric medication on your own. Some medications can cause withdrawal symptoms or other problems when stopped abruptly. Talk with the prescribing clinician about what you are experiencing and how to change the plan safely if a change is needed.
If you're facing symptoms that disrupt your daily life, the team at MindBliss Psychiatry is here to help you regain balance and clarity. Reach out for assistance today!
Text 915-229-5033 to book

915-229-5044

M-F 8am-5pm, Sat-Sun: Closed
Copyright. Mind Bliss - All Rights Reserved
|

Depression (TRD)
Anxiety (GAD)
OCD
Bipolar Disorder
Sleep Disorders
PTSD & Trauma
Concussion Recovery
ADD & ADHD
Chronic Pain
Eating Disorders
Stroke Recovery
Epilepsy
Parkinson's
Migraines
